SOX10 is significantly elevated in bladder carcinomas compared to surrounding healthy tissues [16];Knockdown of SOX10 impacts cancer growth and spread, making it a potential treatment target [16];SOX10 inhibition may affect cancer progression by influencing other components in development pathways such as B-catenin and Met [16];Potential usefulness as a diagnostic marker for bladder cancers [16]. Here, SOX10 is linked to urinary bladder cancer.